BioGenerator Ventures
Venture capitalSt. Louis · Pre-Seed–Series B · 22 people tracked
Investment thesis
BioGenerator Ventures invests in life sciences companies that tackle meaningful problems in human health and agriculture. The firm differentiates itself through BioGenerator Labs, an integrated company-building platform combining proof-of-concept grants, expert mentorship, laboratory facilities, and structured coaching. This infrastructure-plus-capital approach is designed to reduce risk and accelerate progression from concept through early venture funding and revenue generation.
Source: firm website, verified Jul 21, 2026.
Team · 22 people
from the firm's website
What they invest in
from 15 of 23 portfolio companiesBiotech ×14Medical Devices ×10Healthtech ×7Deep Tech ×6AI & Machine Learning ×3Digital Health ×3AgTech ×2Cleantech ×1
HQs:United States×6
Investments · 23 tracked
founders shown can be your intro pathCadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Bob Karr(Executive Chairman & CEO)
Agricultural and food technology company
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples. The company serves research institutions, academic medical centers, and clinical laboratories studying oncology, biomarker discovery, and disease mechanisms.
BiotechHealthtechMedical Devices
Company supported through pre-company stage to growth
Cortex is a non-profit innovation district in St. Louis that provides facilities, programs, and partnerships to support startups, manufacturers, R&D teams, and creators across technology, life sciences, and general sectors. The organization operates a 200-acre development focused on fostering economic growth, job creation, and workforce training in the region.
Enterprise SoftwareGovTechImpact & Social GoodSt. Louis, US
Valo Health applies technology and biotech expertise to advance drug discovery processes. The company focuses on redefining how pharmaceutical research and development is conducted.
AI & Machine LearningBiotech
Agricultural company supported through formation and early growth
Edison Agro Sciences develops bio-based synthetic rubber from sunflower crops as an alternative to petrochemical and natural rubber for industrial applications. The company processes agricultural waste from sunflower farming to create environmentally responsible rubber products for manufacturers seeking to reduce carbon emissions and comply with regulatory requirements.
AgTechBiotechCleantechNew Materials
Clinical diagnostics company demonstrating high sensitivity and specificity in pivotal trials
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Andrew Barnell(Chief Executive Officer & Co-founder)Erica Barnell(Co-founder)
Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy. The company's intellectual property platform includes IP-001, designed to transform routine ablation procedures into systemically active cancer immunotherapy.
BiotechDeep TechDigital HealthMedical DevicesSt. Louis, US
Dr. Hode(Co-Founder & Senior Fellow)Mr. Alleruzzo(Co-Founder & Director)Dr. Chen(Co-Founder)Dr. Robert Nordquist(Co-Founder)
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply. The pre-clinical stage biotech company is supported by federal grants and investor funding.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
<UNKNOWN>Allan Doctor(Co-Founder & CSO)Dipanjan Pan(Co-Founder, Chief Technical Officer)Philip Spinella(Co-Founder, Chief Medical Officer)
Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas. The company serves biopharma firms, clinical laboratories, and medical institutions through a network of clinical collaborators and research partners.
BiotechDeep TechHealthtechMedical Devices
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.
AI & Machine LearningBiotechHealthtechMedical Devices
Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Dr. Harding(Primary Founder)Dr. SzymanskiMario F. FeldmanDr. Projan
Precision medicine and drug discovery platform making metabolomics widely accessible
Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods. The company serves the agricultural industry with next-generation biotechnology solutions.
AgTechBiotech
Jeffrey Staub
RhoDx develops cell-free DNA and RNA enrichment technologies for liquid biopsy cancer diagnostics. The company provides ultra-sensitive mutation detection methods to improve the performance and accessibility of liquid biopsy testing.
BiotechDigital HealthMedical Devices
Charlie Rodi(Founder and CSO)
Spinout from Washington University
Allotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.
BiotechMedical Devices
Frequently asked questions
- What stage does BioGenerator Ventures invest at?
- BioGenerator Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does BioGenerator Ventures focus on?
- BioGenerator Ventures focuses on AgTech, Biotech, Healthtech, Medical Devices.
- Where is BioGenerator Ventures located?
- BioGenerator Ventures is headquartered in St. Louis, US.
- Does BioGenerator Ventures lead rounds?
- Yes, BioGenerator Ventures leads investment rounds.
Similar investors
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
MDI Ventures is a strategic venture capital firm anchored by an evergreen fund from Telkom Indonesia. The firm manages investments across all stages and leverages relationships with Telkom, Indonesian state-owned enterprises, and large Indonesian corporates to create business opportunities and revenue collaboration between portfolio companies and anchor LPs.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.